Results 191 to 200 of about 383,789 (365)
Secondary Electron Hyperspectral Imaging of Carbons: New Insights and Good Practice Guide
Secondary hyperspectral imaging of carbon surfaces is assessed with reference materials and in comparison to standard spectroscopies. Characterization of functional carbon materials from battery research reveals otherwise inaccessible information about the distribution of sp2 and amorphous carbon, as shown in graphite anode and carbon coated lithium ...
James F. Nohl+22 more
wiley +1 more source
This study presents a noval cation‐exchange approach in N, N‐dimethylformamide solvent to synthesize sub‐1‐nm PbSe nanowires, with sub‐1‐nm ZnSe nanowires as the starting material. By capitalizing on the unique near‐infrared absorption characteristics and superior carrier transport properties of these nanowires, this is successfully developed high ...
Xiaoli Li+5 more
wiley +1 more source
Associations Between Dietary Carotenoid Intake and Plasma Carotenoid Concentrations and Skin Yellowness, a Validation Study. [PDF]
Clarke ED+8 more
europepmc +1 more source
Schematic model of CJP–TiN liposomes for gastric cancer (GC) treatment. Internalizing RGD peptide (iRGD) targets tumor cells, while Chlorin e6 (Ce6) generates reactive oxygen species (ROS). Jolkinolide B (JB) activates the PANoptosis pathway via caspase‐8, enhancing GC cell death and immune response, transforming “cold tumors” into “hot tumors” by ...
Chenhui Ma+14 more
wiley +1 more source
Yuhao Wang+3 more
semanticscholar +1 more source
Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system. [PDF]
Teng H, Zhang S, Yu J, Li F.
europepmc +1 more source
By engineering bifunctional nitrogen‐dislocation interactions, this work constructs a heterogeneous lamellar structure with N‐rich low‐angle boundaries and coherent nanotwinned martensites, enabling ultrahigh yield/tensile strength (1532/1869 MPa) and activating massive
Chongle Zhang+5 more
wiley +1 more source
Recording and reporting of adverse events during a randomized controlled trial of cognitive behavioural therapy for insomnia (CBT-I) among cancer survivors. [PDF]
Greeley KM+6 more
europepmc +1 more source